Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases
Creators
- 1. Department of Radiation Oncology, C. Regaud Institute, Toulouse (France)
- 2. Department of Radiation Oncology, Bergonie Institute, Bordeaux (France)
- 3. Bone Surgery Department, Purpan Hospital, Toulouse (France)
- 4. Department of Medical Oncology, C. Regaud Institute, Toulouse (France)
- 5. Department of Surgery, Bergonie Institute, Bordeaux (France)
- 6. Department of Surgery, C. Regaud Institute, Toulouse (France)
- 7. Department of Pathology, C. Regaud Institute, Toulouse (France)
- 8. Department of Pathology, Bergonie Institute, Bordeaux (France)
- 9. Department of Epidemiology, P. Sabatier University, Toulouse (France)
Description
Purpose: To analyze the management and clinical outcome of patients treated for a first isolated local recurrence of soft tissue sarcomas (trunk or extremities) and to identify prognosis factors. Methods and material: Between 1980 and 1999, 83 adult patients were included in the study. Mean age was 61 years. Mean tumor size was 6 cm. Most sarcomas were located in extremities were deep , and proximal ; 30 involved nerves or vessels. Histologic subtypes were mainly grade 2 (42%) or 3 (36%) histiocytofibrosarcomas (49%) and liposarcomas (20%). Surgical treatment of recurrences consisted in wide excision (29 cases), marginal resection (43 cases), 5 patients requiring amputation. Final results were R0 , R1 or R2 resection. Besides surgery, 6 patients received neo-adjuvant and 7 others adjuvant chemotherapy. Twenty three patients received post-operative external beam radiotherapy (EBRT) (mean dose 55 Gy) and 26 interstitial 192Ir low dose rate brachytherapy (BCT) (mean dose 45 Gy for BCT alone, 22 Gy when associated with EBRT), 19 patients being re-irradiated. Results: Mean follow up was 13 years. Thirty-seven (45%) patients relapsed, 62% of whom presenting an isolated local recurrence. Nineteen patients developed distant metastases. Multivariate analysis showed only tumor depth (P=0.05) and re-resection for primary R1 resection (P=0.018) being independent prognosis factors for tumor control, radiotherapy (EBRT and/or BCT) being significant in univariate analysis (P=0.05). Overall survival rate was 73%, 54%, and 47% at, respectively, 3.5 and 10 years, and was 65%, 35% and 32% after a further local recurrence. Multivariate analysis showed trunk (P=0.0001) or inferior extremity locations (P=0.023), symptomatic (P=0.001), high grade (P=0.01), deep (P=0.01) tumors, and the occurrence of a further local failure (P=0.004) as unfavorable characteristics for overall survival. Conclusions: A first isolated local recurrence of STS increases mainly the risk of a subsequent local relapse. Quality of local treatment is decisive. When a conservative treatment is feasible, it should combine surgical resection and radiotherapy, BCT being the best suited in previously irradiated patients. Efforts have to be pursued to increase quality of the treatment of primary tumors, at best performed in centers that have expertise in this field
Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2004.05.008;
- PII
- S0167-8140(04)00326-3;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 73
- Journal Issue
- 3
- Journal Page Range
- p. 313-319
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 36074462
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRACHYTHERAPY; CHEMOTHERAPY; DOSE RATES; HAZARDS; IRIDIUM 192; IRRADIATION; METASTASES; NERVES; PATIENTS; RADIATION DOSES; SARCOMAS; SURGERY
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DISEASES; DOSES; ELECTRON CAPTURE RADIOISOTOPES; HEAVY NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IRIDIUM ISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MEDICINE; MINUTES LIVING RADIOISOTOPES; NEOPLASMS; NERVOUS SYSTEM; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; THERAPY; YEARS LIVING RADIOISOTOPES
Optional Information
- Copyright
- Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.